Antidepressant Medication Does Not Contribute to the Elevated Circulating Concentrations of Acylethanolamides Found in Substance Use Disorder Patients
Circulating acylethanolamides (NAEs) are bioactive signaling molecules that modulate multiple homeostatic functions including mood and hedonic responses. Variations in their plasma concentrations are associated with substance use disorders (SUD) and recent studies suggest that psychotropic medicatio...
Main Authors: | Jesús Herrera-Imbroda, María Flores-López, Nerea Requena-Ocaña, Pedro Araos, Nuria García-Marchena, Jessica Ropero, Antonio Bordallo, Juan Suarez, Francisco J. Pavón-Morón, Antonia Serrano, Fermín Mayoral, Fernando Rodríguez de Fonseca |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/19/14788 |
Similar Items
-
Antipsychotic Medication Influences the Discriminative Value of Acylethanolamides as Biomarkers of Substance Use Disorder
by: Jesús Herrera-Imbroda, et al.
Published: (2023-05-01) -
Glial modulation by N-acylethanolamides in brain injury and neurodegeneration
by: María Inés Herrera, et al.
Published: (2016-04-01) -
N-acylethanolamide metabolizing enzymes are upregulated in human neural progenitor-derived neurons exposed to sub-lethal oxidative stress
by: R. Scott Duncan, et al.
Published: (2022-08-01) -
Oleoylethanolamide, Neuroinflammation, and Alcohol Abuse
by: Laura Orio, et al.
Published: (2019-01-01) -
Palmitoylethanolamide Reduces Colon Cancer Cell Proliferation and Migration, Influences Tumor Cell Cycle and Exerts In Vivo Chemopreventive Effects
by: Ester Pagano, et al.
Published: (2021-04-01)